64°
Feels Like: 64°
52°
57°
41°
By Verna Gates BIRMINGHAM, Alabama (Reuters) - U.S. and state health authorities are investigating an unidentified respiratory illne...
Read More »
WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at th...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their phar...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Daily vitamin C supplements don't lower uric acid as much as drugs used to treat hig...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Adults who drink at least one sugar-sweetened drink a day are slightly more likely to dev...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - More than one quarter of people being treated for non-melanoma skin cancer in their d...
Read More »By Bill Berkrot NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipe...
Read More »(Reuters) - Montreal, Canada's second-largest city, has asked 1.3 million people to boil their drinking water after a problem at one...
Read More »
FRANKFURT (Reuters) - German software company SAP is looking to recruit people with autism as programmers and product testers, drawi...
Read More »(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main ...
Read More »
